588 related articles for article (PubMed ID: 28009106)
1. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
Mobini R; Tremaroli V; Ståhlman M; Karlsson F; Levin M; Ljungberg M; Sohlin M; Bertéus Forslund H; Perkins R; Bäckhed F; Jansson PA
Diabetes Obes Metab; 2017 Apr; 19(4):579-589. PubMed ID: 28009106
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial.
Hsieh MC; Tsai WH; Jheng YP; Su SL; Wang SY; Lin CC; Chen YH; Chang WW
Sci Rep; 2018 Nov; 8(1):16791. PubMed ID: 30429496
[TBL] [Abstract][Full Text] [Related]
3.
García Contreras AA; Vásquez Garibay EM; Sánchez Ramírez CA; Fafutis Morris M; Delgado Rizo V
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998471
[TBL] [Abstract][Full Text] [Related]
4. Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept.
Simon MC; Strassburger K; Nowotny B; Kolb H; Nowotny P; Burkart V; Zivehe F; Hwang JH; Stehle P; Pacini G; Hartmann B; Holst JJ; MacKenzie C; Bindels LB; Martinez I; Walter J; Henrich B; Schloot NC; Roden M
Diabetes Care; 2015 Oct; 38(10):1827-34. PubMed ID: 26084343
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
Tenorio-Jiménez C; Martínez-Ramírez MJ; Tercero-Lozano M; Arraiza-Irigoyen C; Del Castillo-Codes I; Olza J; Plaza-Díaz J; Fontana L; Migueles JH; Olivares M; Gil Á; Gomez-Llorente C
BMC Complement Altern Med; 2018 Nov; 18(1):306. PubMed ID: 30453950
[TBL] [Abstract][Full Text] [Related]
6. Effects of
Martí M; Spreckels JE; Ranasinghe PD; Wejryd E; Marchini G; Sverremark-Ekström E; Jenmalm MC; Abrahamsson T
Cell Rep Med; 2021 Mar; 2(3):100206. PubMed ID: 33763652
[TBL] [Abstract][Full Text] [Related]
7. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.
Jones ML; Martoni CJ; Prakash S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2944-51. PubMed ID: 23609838
[TBL] [Abstract][Full Text] [Related]
8. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
[TBL] [Abstract][Full Text] [Related]
9. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life.
Abrahamsson TR; Sinkiewicz G; Jakobsson T; Fredrikson M; Björkstén B
J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):349-54. PubMed ID: 19525871
[TBL] [Abstract][Full Text] [Related]
10. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
12. The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial.
Razmpoosh E; Javadi A; Ejtahed HS; Mirmiran P; Javadi M; Yousefinejad A
Diabetes Metab Syndr; 2019; 13(1):175-182. PubMed ID: 30641692
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.
Tonucci LB; Olbrich Dos Santos KM; Licursi de Oliveira L; Rocha Ribeiro SM; Duarte Martino HS
Clin Nutr; 2017 Feb; 36(1):85-92. PubMed ID: 26732026
[TBL] [Abstract][Full Text] [Related]
14. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial.
Firouzi S; Majid HA; Ismail A; Kamaruddin NA; Barakatun-Nisak MY
Eur J Nutr; 2017 Jun; 56(4):1535-1550. PubMed ID: 26988693
[TBL] [Abstract][Full Text] [Related]
15. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults.
Zhang C; Jiang J; Wang C; Li S; Yu L; Tian F; Zhao J; Zhang H; Chen W; Zhai Q
Clin Nutr; 2022 Feb; 41(2):365-373. PubMed ID: 34999331
[TBL] [Abstract][Full Text] [Related]
17. Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial.
Drenthen LCA; de Baaij JHF; Rodwell L; van Herwaarden AE; Tack CJ; de Galan BE
Diabetologia; 2024 Jan; 67(1):52-61. PubMed ID: 37922013
[TBL] [Abstract][Full Text] [Related]
18. Probiotics Lactobacillus reuteri DSM 17938 and Lactobacillus casei CRL 431 modestly increase growth, but not iron and zinc status, among Indonesian children aged 1-6 years.
Agustina R; Bovee-Oudenhoven IM; Lukito W; Fahmida U; van de Rest O; Zimmermann MB; Firmansyah A; Wulanti R; Albers R; van den Heuvel EG; Kok FJ
J Nutr; 2013 Jul; 143(7):1184-93. PubMed ID: 23700339
[TBL] [Abstract][Full Text] [Related]
19. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial.
Akkasheh G; Kashani-Poor Z; Tajabadi-Ebrahimi M; Jafari P; Akbari H; Taghizadeh M; Memarzadeh MR; Asemi Z; Esmaillzadeh A
Nutrition; 2016 Mar; 32(3):315-20. PubMed ID: 26706022
[TBL] [Abstract][Full Text] [Related]
20. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.
Sung V; Hiscock H; Tang ML; Mensah FK; Nation ML; Satzke C; Heine RG; Stock A; Barr RG; Wake M
BMJ; 2014 Apr; 348():g2107. PubMed ID: 24690625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
